Maynard Um
-
-
-
-
-
-
-
BMO Capital Starts Insmed (INSM) at Outperform
-
-
-
-
-
-
-
Insmed (INSM) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Insmed (INSM) PT Raised to $230 at Guggenheim
-
-
-
-
-
-
-
Truist Securities on Insmed (INSM): brensocatib in HS failure unsuprising, 'stock doesn't reflect any meaningful value for HS'
-
-
-
-
-
-
-
Insmed (INSM) PT Raised to $245 at H.C. Wainwright
-
-
-
-
-
-
-
Wolfe Research on Insmed (INSM): 'expect stock to converge toward PT over next few quarters'
-
-
-
-
-
-
-
Insmed (INSM) PT Lowered to $205 at Stifel
-
441,837 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

